Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Abeona Therapeutics Inc (ABEO) vs General Motors Company (GM) Price & Performance

Abeona Therapeutics IncTrade
General Motors CompanyTrade

Price performance (Past 24H)

Key statistics

Abeona Therapeutics Inc vs General Motors Company — how do they compare? Abeona Therapeutics Inc trades at $7.57 (market cap $421.19M), while General Motors Company trades at $89.19 (market cap $78.40B). The key difference: General Motors Company is far larger — about 186.1× Abeona Therapeutics Inc's market cap, and General Motors Company pays a 0.81% dividend while Abeona Therapeutics Inc pays none. Which is the better fit depends on your goals.

ABEOGM
Market Cap
$421.19M$78.40B
Sector
HealthConsumer Cyclical
52-Week High
$7.45$90.30
52-Week Low
$4.17$54.16
Enterprise Value
$276.10M$181.38B
Dividend Yield
0.81%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Abeona Therapeutics Inc

Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.

Read more on ABEO

About General Motors Company

General Motors Co. emerged from the bankruptcy of General Motors Corp. (old GM) in July 2009. GM has eight brands and operates under four segments: GM North America, GM International, Cruise, and GM Financial. The United States now has four brands instead of eight under old GM. The company lost its U.S. market share leader crown in 2021 with share down 280 basis points to 14.6%, but we expect GM to reclaim the top spot in 2022 as 2021 suffered from the chip shortage. GM Financial became the company's captive finance arm in October 2010 via the purchase of AmeriCredit.

Read more on GM